Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


From Military To Medicine, Owlstone Medical Targets Lung Cancer With Its Breath Analysis Tech

Executive Summary

Owlstone Medical is on a mission to “save 100,000 lives and £1.5bn in health-care costs by 2020” by applying a gas sensor technology, originally developed for military defense purposes, for early stage detection of lung cancer.

You may also be interested in...

TTP Ventus Pumps New Technology Into Wearable Sleep Apnea Treatment

A micropump technology from UK company TTP Ventus is powering a new wearable sleep apnea product developed by San Diego-based company Sommetrics. The device is currently approved for marketing to people with all degrees of sleep apnea in Canada. TTP's pump know-how is also being applied to IVD technologies, including a breathalyzer and microfluidic-based diagnostic devices.

Market Intel: Can New Wave Of Tests Finally Nail Early Diagnosis Of Lung Cancer?

Early diagnosis of lung cancer continues to be a major clinical challenge and the opportunity for products that can successfully detect the disease early enough to boost survival rate is huge. This article looks into the market potential and highlights companies developing technologies that they believe can finally turn this deadliest of cancers on its head.

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts